St. Louis Park, MN, United States of America

Daniel A Vallera

USPTO Granted Patents = 15 

Average Co-Inventor Count = 1.9

ph-index = 5

Forward Citations = 120(Granted Patents)


Location History:

  • Minneapolis, MN (US) (1989 - 2016)
  • St. Louis Park, MN (US) (1999 - 2021)
  • Richfield, MN (US) (2021)

Company Filing History:


Years Active: 1989-2025

Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel A Vallera

Introduction

Daniel A Vallera is an accomplished inventor based in St. Louis Park, Minnesota, with a remarkable portfolio that consists of 15 patents. His work primarily focuses on the fields of immunology and cancer treatment, showcasing his dedication to advancing medical science through innovative solutions.

Latest Patents

One of Vallera's latest inventions is centered around NK engager molecules and their methods of use. This groundbreaking patent provides compositions aimed at activating natural killer (NK) cells to stimulate immune responses for treating cancer and various other disorders. The invention includes a compound comprising an NK engaging domain that binds to CD16, an NK activating domain operably linked to the NK engaging domain, and a targeting domain that selectively binds to a target cell, specifically CLEC12A. Additionally, Vallera's patent includes anti-canine CD16 and CD64 polypeptides, which offer therapeutic potential through their incorporation into various types of compounds, including multispecific and targeted imaging compounds.

Career Highlights

Daniel Vallera has had a distinguished career, contributing significantly to the field of immunotherapy through his research and inventions. He has held positions at notable institutions, including the University of Minnesota, where his work has made a lasting impact on cancer treatment methodologies. His innovative spirit and dedication to research have positioned him as a leading figure in the development of novel therapies.

Collaborations

Throughout his career, Vallera has collaborated with esteemed colleagues, including Bruce Robert Blazar and Jeffrey S. Miller. These partnerships have fostered an environment of innovation and mutual support, contributing to the successful development of his patents and research initiatives.

Conclusion

Daniel A Vallera exemplifies the role of a visionary inventor making strides in the fields of immunology and cancer treatment. Through his 15 patents, he continues to pave the way for advances in medical science, highlighting the critical link between innovation and improved healthcare outcomes. His work not only enhances our understanding of immune responses but also promises new avenues for therapeutic intervention in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…